نمایش پرونده ساده آیتم

dc.contributor.authorSafdari, Y
dc.contributor.authorKhalili, M
dc.contributor.authorFarajnia, S
dc.contributor.authorAsgharzadeh, M
dc.contributor.authorYazdani, Y
dc.contributor.authorSadeghi, M
dc.date.accessioned2018-08-26T07:55:43Z
dc.date.available2018-08-26T07:55:43Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/48549
dc.description.abstractThe current review presents the results of the most recent studies performed on different aspects of human head and neck squamous cell carcinoma, including radiosensitivity induction, efficiency improvement of monoclonal antibodies using low-intensity ultrasound, chemical compounds such as toll-like receptor (TLC) agonists, dasatinib, resveratrol and niclosamide, nuclear inhibition of cancer using STAT3 decoy oligonucleotide, efficiency of anti-EGFR monoclonal antibodies in detection of head and neck cancers and other related issues. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofCLINICAL BIOCHEMISTRY
dc.subjectHead and neck cancer
dc.subjectEGFR
dc.subjectApoptosis
dc.subjectRadiosensitivity
dc.subjectCetuximab
dc.subjectErlotinib
dc.titleRecent advances in head and neck squamous cell carcinoma - A review
dc.typeReview
dc.citation.volume47
dc.citation.issue13-14
dc.citation.spage1195
dc.citation.epage1202
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.clinbiochem.2014.05.066


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم